Chargement en cours...

5-Lipoxygenase-Activating Protein as a Modulator of Olanzapine-Induced Lipid Accumulation in Adipocyte

Experiments were performed in 3T3-L1 preadipocytes differentiated in vitro into adipocytes. Cells were treated with olanzapine and a 5-lipoxygenase (5-LOX) activating protein (FLAP) inhibitor MK-886. Lipid content was measured using an Oil Red O assay; 5-LOX and FLAP mRNA content was measured using...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Dzitoyeva, Svetlana, Chen, Hu, Manev, Hari
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2013
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3677661/
https://ncbi.nlm.nih.gov/pubmed/23762565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/864593
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!